Department of Chemistry and Biochemistry, The Ohio State University, 100 West 18th Avenue, Columbus, Ohio 43210, United States.
Department of Chemistry, Boston University, 590 Commonwealth Avenue, Boston, Massachusetts 02215, United States.
Inorg Chem. 2020 Dec 7;59(23):17712-17721. doi: 10.1021/acs.inorgchem.0c02923. Epub 2020 Nov 20.
Complexes of Fe engage in rich aqueous solution speciation chemistry in which discrete molecules can react with solvent water to form multinuclear μ-oxo and μ-hydroxide bridged species. Here we demonstrate how pH- and concentration-dependent equilibration between monomeric and μ-oxo-bridged dimeric Fe complexes can be controlled through judicious ligand design. We purposed this chemistry to develop a first-in-class Fe-based MR imaging probe, Fe-PyCy2AI, that undergoes relaxivity change via pH-mediated control of monomer vs dimer speciation. The monomeric complex exists in a = 5/2 configuration capable of inducing efficient -relaxation, whereas the antiferromagnetically coupled dimeric complex is a much weaker relaxation agent. The mechanisms underpinning the pH dependence on relaxivity were interrogated by using a combination of pH potentiometry, H and O relaxometry, electronic absorption spectroscopy, bulk magnetic susceptibility, electron paramagnetic resonance spectroscopy, and X-ray crystallography measurements. Taken together, the data demonstrate that PyCy2AI forms a ternary complex with high-spin Fe and a rapidly exchanging water coligand, [Fe(PyCy2AI)(HO)] (), which can deprotonate to form the high-spin complex [Fe(PyCy2AI)(OH)] (). Under titration conditions of 7 mM Fe complex, water coligand deprotonation occurs with an apparent p 6.46. Complex dimerizes to form the antiferromagnetically coupled dimeric complex [(Fe(PyCy2AI))O] () with an association constant () of 5.3 ± 2.2 mM. The relaxivity of the monomeric complexes are between 7- and 18-fold greater than the antiferromagnetically coupled dimer at applied field strengths ranging between 1.4 and 11.7 T. and interconvert rapidly within the pH 6.0-7.4 range that is relevant to human pathophysiology, resulting in substantial observed relaxivity change. Controlling Fe μ-oxo bridging interactions through rational ligand design and in response to local chemical environment offers a robust mechanism for biochemically responsive MR signal modulation.
铁的配合物在富含水的溶液中表现出丰富的形态化学,其中离散的分子可以与溶剂水反应,形成多核μ-氧和μ-氢氧化物桥联物种。在这里,我们展示了如何通过明智的配体设计来控制单体和μ-氧桥联二聚体铁配合物之间的 pH 和浓度依赖的平衡。我们的目的是开发一种首创的基于铁的磁共振成像探针,Fe-PyCy2AI,它通过 pH 介导的单体与二聚体形态控制来改变弛豫率。单体配合物存在于 = 5/2 构型中,能够诱导有效的 -弛豫,而反铁磁耦合的二聚体配合物则是一种较弱的弛豫剂。通过使用 pH 电位滴定、H 和 O 弛豫率、电子吸收光谱、体磁化率、电子顺磁共振波谱和 X 射线晶体学测量的组合,研究了 pH 对弛豫率的影响机制。综合来看,这些数据表明 PyCy2AI 与高自旋 Fe 和快速交换的水配位体形成三元配合物,[Fe(PyCy2AI)(HO)] (),它可以去质子化形成高自旋配合物[Fe(PyCy2AI)(OH)] ()。在 7 mM Fe 配合物的滴定条件下,水配位体去质子化发生在表观 p 6.46 处。配合物二聚形成反铁磁耦合二聚体配合物[(Fe(PyCy2AI))O] (),其缔合常数()为 5.3 ± 2.2 mM。在 1.4 至 11.7 T 之间的应用场强下,单体配合物的弛豫率比反铁磁耦合二聚体高 7 至 18 倍。[Fe(PyCy2AI)(HO)] ()和[Fe(PyCy2AI)(OH)] ()在 pH 6.0-7.4 范围内快速相互转换,这与人体病理生理学相关,导致观察到的弛豫率发生显著变化。通过合理的配体设计和响应局部化学环境控制铁的 μ-氧桥接相互作用,为生物化学响应性磁共振信号调制提供了一种稳健的机制。